| # | Title | Journal | Year | Citations |
|---|
| 1 | First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial | Lancet, The | 2017 | 438 |
| 2 | Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial | Lancet Oncology, The | 2020 | 330 |
| 3 | Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials | European Journal of Cancer | 2017 | 160 |
| 4 | Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland | Journal of the American Academy of Dermatology | 2018 | 127 |
| 5 | Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC) | European Journal of Cancer | 2019 | 120 |
| 6 | A Severe Case of Ipilimumab-Induced Guillain-Barré Syndrome Revealed by an Occlusive Enteric Neuropathy | Journal of Immunotherapy | 2013 | 89 |
| 7 | Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population | Journal of Investigative Dermatology | 2019 | 69 |
| 8 | Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score ( ABSIS ) and Pemphigus Disease Area Index ( PDAI ) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus | British Journal of Dermatology | 2016 | 68 |
| 9 | Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915) | Journal of Clinical Oncology | 2023 | 59 |
| 10 | Food‐induced anaphylaxis in infancy compared to preschool age: A retrospective analysis | Clinical and Experimental Allergy | 2020 | 58 |
| 11 | Line‐field confocal optical coherence tomography of basal cell carcinoma: a descriptive study | Journal of the European Academy of Dermatology and Venereology | 2021 | 58 |
| 12 | Large International Validation of ABSIS and PDAI Pemphigus Severity Scores | Journal of Investigative Dermatology | 2019 | 55 |
| 13 | Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect | British Journal of Dermatology | 2020 | 55 |
| 14 | Sinonasal mucosal melanomas: The prognostic value of tumor classifications | Head and Neck | 2014 | 48 |
| 15 | Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study | British Journal of Dermatology | 2011 | 47 |
| 16 | Invivo characterization of healthy human skin with a novel, non‐invasive imaging technique: line‐field confocal optical coherence tomography | Journal of the European Academy of Dermatology and Venereology | 2020 | 45 |
| 17 | Development and accuracy of an artificial intelligence algorithm for acne grading from smartphone photographs | Experimental Dermatology | 2019 | 44 |
| 18 | Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy | JAMA Dermatology | 2020 | 40 |
| 19 | Dacarbazine with or without oblimersen (a Bcl-2 antisense oligonucleotide) in chemotherapy-naive patients with advanced melanoma and low–normal serum lactate dehydrogenase | Melanoma Research | 2014 | 32 |
| 20 | Epithelial barrier dysfunction in desmoglein-1 deficiency | Journal of Allergy and Clinical Immunology | 2018 | 31 |
| 21 | Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE‐4 scale’ | Journal of the European Academy of Dermatology and Venereology | 2018 | 26 |
| 22 | Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study | Rheumatology | 2021 | 17 |
| 23 | Clinical, biological and histological characteristics of bullous pemphigoid associated with anti‐PD‐1/PD‐L1 therapy: A national retrospective study | Journal of the European Academy of Dermatology and Venereology | 2021 | 17 |
| 24 | Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria | European Journal of Cancer | 2022 | 16 |
| 25 | Predictors of long‐term drug survival for infliximab in psoriasis | Journal of the European Academy of Dermatology and Venereology | 2017 | 15 |
| 26 | Mucous membrane pemphigoid of the oral lichen type: a retrospective analysis of 16 cases | Journal of the European Academy of Dermatology and Venereology | 2019 | 13 |
| 27 | Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical Trial | Patient | 2020 | 11 |
| 28 | Does mandibular third molar have an impact on dental mandibular anterior crowding? A literature review | Journal of Stomatology, Oral and Maxillofacial Surgery | 2018 | 10 |
| 29 | Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib | European Journal of Cancer | 2021 | 9 |
| 30 | Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function | Seminars in Arthritis and Rheumatism | 2017 | 8 |
| 31 | Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis | JAMA Dermatology | 2023 | 5 |
| 32 | Is mogamulizumab-induced alopecia areata associated with favorable outcomes in Sézary syndrome? | European Journal of Cancer | 2021 | 4 |
| 33 | ICOS Is Widely Expressed in Cutaneous T-Cell Lymphoma and Its Targeting Promotes Potent Killing of Malignant Cells | Blood | 2021 | 4 |
| 34 | Combined treatment of hypertrophic and keloid scars with intralesional injection of corticosteroids and laser‐assisted corticosteroid delivery | Dermatologic Therapy | 2019 | 3 |
| 35 | An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastases | European Journal of Cancer | 2022 | 3 |
| 36 | TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy | Journal of Translational Medicine | 2016 | 2 |
| 37 | Desensitization protocol for angio‐oedema induced by encorafenib in a patient with metastatic melanoma | Journal of the European Academy of Dermatology and Venereology | 2019 | 2 |
| 38 | Effect of expression of ICOS in cutaneous T-cell lymphoma and its targeting on killing of malignant cells. | Journal of Clinical Oncology | 2020 | 2 |
| 39 | Treatment of folliculitis decalvans by photodynamic therapy using a new light-emitting device: A case series of 4 patients | JAAD Case Reports | 2021 | 2 |
| 40 | An open-label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib for patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma | Annals of Oncology | 2018 | 1 |
| 41 | Cutaneous sporotrichoid leishmaniasis treated with oral fluconazole | Dermatologic Therapy | 2019 | 1 |
| 42 | Self‐injection of a solution intended for topical use containing hyaluronic acid and vitamin B5 | Clinical and Experimental Dermatology | 2020 | 1 |
| 43 | ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells | European Journal of Cancer | 2021 | 1 |
| 44 | Reply to: “Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?” | Journal of the American Academy of Dermatology | 2018 | 0 |
| 45 | Cutaneous shrinkage after surgical resection of facial skin tumours: a prospective study on 100 surgical specimens | Clinical and Experimental Dermatology | 2019 | 0 |
| 46 | Multiple venous malformations revealing a familial cerebral cavernomatosis | Clinical and Experimental Dermatology | 2020 | 0 |
| 47 | Severe dermatomyositis revealing a thymic carcinoma: Did rituximab delay the diagnosis? | Dermatologic Therapy | 2020 | 0 |
| 48 | Chimerized Anti-ICOS 314.8 Monoclonal Antibodies Inhibit Tumor Cells and Regulatory T Cells in Patients with Sézary Syndrome | Blood | 2021 | 0 |
| 49 | Prevalence of excessive daytime sleepiness among patients with atopic dermatitis | Skin Health and Disease | 2023 | 0 |
